Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.34 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.34 |
| ▸ | ACP1 | P24666 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21020285 | 0.89 | MEN1 (0.30) | MEN1LMNAMAPTKMT2AGPR55 | |
| SCHEMBL20172835 | 0.87 | ACP1 (0.33) | ACP1ELANEALDH1A1MEN1MAPT | |
| SCHEMBL20650495 | 0.86 | NR1H2 (0.33) | NR1H2NR1H3ELANE | |
| SCHEMBL23967662 | 0.84 | CYP1A2 (0.38) | SMN1; SMN2ALDH1A1TP53LMNAMAPT | |
| SCHEMBL21020447 | 0.83 | CYP1A2 (0.32) | — | |
| SCHEMBL21020294 | 0.83 | HDAC6 (0.32) | ACP1ALDH1A1 | |
| SCHEMBL20172837 | 0.83 | ACP1 (0.35) | ACP1MEN1KMT2A | |
| SCHEMBL21021478 | 0.80 | CYP1A2 (0.31) | — | |
| SCHEMBL21020264 | 0.79 | LMNA (0.39) | ALDH1A1TP53MEN1LMNAMAPT | |
| SCHEMBL20172842 | 0.79 | ACP1 (0.33) | ACP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ETV6, ESR1 | NR1H2 1574/4885NR1H3 1237/4885ACP1 4663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.